Drug Trial Radar · NCT01358357
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Last checked: Nov 19, 2026Latest source record: Sep 7, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
965
Actual
Start
Jun 2011
Primary completion
Apr 2015
Study completion Apr 2015
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, placebo-controlled, flexible-dose, parallel-group study designed to evaluate the efficacy and safety of lurasidone (in combination with lithium or divalproex) for the maintenance treatment of bipolar I disorder in subjects with or without rapid cycling and /or psychotic features.
Conditions
- Bipolar I Disorder
Interventions
LurasidoneDrug
Lurasidone 20 mg daily (days 1-3), Lurasidone 40 mg daily (days 4-7), Lurasidone 20-80 mg daily (flexible dose) thereafter
PlaceboDrug
20-80 mg flexible dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Recurrence of Mood Event During the Double Blind Treatment PhaseTime frame: 28 weeks (up to 33 weeks)
Locations
105 sites in 14 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
Behavioral Research Specialists, LLC
Glendale, California
AXIS Clinical Trials
Los Angeles, California
Excell Research, Inc.
Oceanside, California
Stanford University School of Medicine Research Program VA Palo Alto Health Care System
Palo Alto, California
SF-CARE, Inc.
San Francisco, California
Neuropsychiatric Research Center of Orange County
Santa Ana, California
"Stanford University School of Medicine
Stanford, California
Florida Clinical Research LLC
Bradenton, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Galiz Research
Miami Springs, Florida
Clinical Neuroscience Solutions
Orlando, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Clinco
Terre Haute, Indiana
ActivMed Practices & Research Inc.
Haverhill, Massachusetts
Psych Care Consultants Research
St Louis, Missouri
Village Clinical Research Inc,
New York, New York
Finger Lakes Clinical Research
Rochester, New York
Charak Center for Health and Wellness
Garfield Heights, Ohio
Cutting Edge Research Groupd
Oklahoma City, Oklahoma
Suburban Research Associates
Media, Pennsylvania
Lincoln Research
Lincoln, Rhode Island
Carolina Clinical Trials, Inc.
Charleston, South Carolina
Clinical Neuroscience Solutions Inc.
Memphis, Tennessee
Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center
Dallas, Texas
R/D Clinical Research, Inc.
Lake Jackson, Texas
Novain Neurociencias Group
Buenos Aires, Argentina
Centro de Neuropsiquiatria
Buenos Aires, Argentina
IPEM-Instituto de Prevención de las Enfermedades Mentales.
Buenos Aires, Argentina
Instituto DAMCI
Córdoba, Argentina
Clinica Privada de Salud Mental Santa Teresa de Avila
La Plata, Argentina
Centro de Psiquiatria Biologica
Mendoza, Argentina
Sanatorio Morra
Córdoba, Córdoba Province, Argentina
Centro de Atencion E Invest. Clinica (CAICI)
Rosario, Santa Fe Province, Argentina
The Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia
RWF Medic Pty Ltd as Trustee for Farnbach Family Trust at Neurotherapy Victoria
Malvern, Victoria, Australia
The Melbourne Clinic
Richmond, Victoria, Australia
Hollywood Medical Centre
Fremantle, Western Australia, Australia
Psychiatry Dispensary
Burgas, Bulgaria
University Multiprofiled Hospital for Active Treatment "Sveti Georgi"
Plovdiv, Bulgaria
Showing 40 of 105 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.